Literature DB >> 19371207

Estrogen, aging and the cardiovascular system.

James P Stice1, Jennifer S Lee, Angela S Pechenino, Anne A Knowlton.   

Abstract

Estrogen is a powerful hormone with pleiotropic effects. Estrogens have potent antioxidant effects and are able to reduce inflammation, induce vasorelaxation and alter gene expression in both the vasculature and the heart. Estrogen treatment of cultured cardiac myocytes and endothelial cells rapidly activates NFkappaB, induces heat-shock protein (HSP)-72, a potent intracellular protective protein, and protects cells from simulated ischemia. In in vivo models, estrogens protect against ischemia and trauma/hemorrhage. Estrogens may decrease the expression of soluble epoxide hydrolase, which has deleterious effects on the cardiovascular system through metabolism of epoxyeicosatrienoic acids. Natural (endogenous) estrogens in premenopausal women appear to protect against cardiovascular disease and yet controlled clinical trials have not indicated a benefit from estrogen replacement postmenopause. Much remains to be understood in regards to the many properties of this powerful hormone and how changes in this hormone interact with aging-associated changes. The unexpected negative results of trials of estrogen replacement postmenopause probably arise from our lack of understanding of the many effects of this hormone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371207      PMCID: PMC3972065          DOI: 10.2217/14796678.5.1.93

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  86 in total

1.  Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats.

Authors:  Virginija Jazbutyte; Kai Hu; Patricia Kruchten; Emmanuel Bey; Sebastian K G Maier; Karl-Heinrich Fritzemeier; Katja Prelle; Christa Hegele-Hartung; Rolf W Hartmann; Ludwig Neyses; Georg Ertl; Theo Pelzer
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

Review 2.  The molecular inflammatory process in aging.

Authors:  Hae Young Chung; Bokyung Sung; Kyung Jin Jung; Yani Zou; Byung Pal Yu
Journal:  Antioxid Redox Signal       Date:  2006 Mar-Apr       Impact factor: 8.401

3.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

4.  Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Authors:  John M Seubert; Christopher J Sinal; Joan Graves; Laura M DeGraff; J Alyce Bradbury; Craig R Lee; Kerry Goralski; Michelle A Carey; Ayala Luria; John W Newman; Bruce D Hammock; John R Falck; Holly Roberts; Howard A Rockman; Elizabeth Murphy; Darryl C Zeldin
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

Review 5.  Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

Authors:  Judith L Turgeon; Molly C Carr; Pauline M Maki; Michael E Mendelsohn; Phyllis M Wise
Journal:  Endocr Rev       Date:  2006-06-09       Impact factor: 19.871

6.  Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.

Authors:  Danyan Xu; Ning Li; Yuxia He; Valeriy Timofeyev; Ling Lu; Hsing-Ju Tsai; In-Hae Kim; Dipika Tuteja; Robertino Karlo P Mateo; Anil Singapuri; Benjamin B Davis; Reginald Low; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

7.  Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms.

Authors:  Jin Kyung Kim; Ali Pedram; Mahnaz Razandi; Ellis R Levin
Journal:  J Biol Chem       Date:  2005-12-30       Impact factor: 5.157

8.  Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models.

Authors:  P M Wise
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

9.  Tumor necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats.

Authors:  Ivan A Arenas; Stephen J Armstrong; Yi Xu; Sandra T Davidge
Journal:  Hypertension       Date:  2006-07-24       Impact factor: 10.190

Review 10.  Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Authors:  Bora Inceoglu; Kara R Schmelzer; Christophe Morisseau; Steve L Jinks; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-07-05       Impact factor: 3.072

View more
  29 in total

1.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 2.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 3.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

Review 4.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

5.  The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes.

Authors:  Anna Grazia Recchia; Ernestina Marianna De Francesco; Adele Vivacqua; Diego Sisci; Maria Luisa Panno; Sebastiano Andò; Marcello Maggiolini
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

Review 6.  Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.

Authors:  Anne M Etgen; Teresa Jover-Mengual; R Suzanne Zukin
Journal:  Front Neuroendocrinol       Date:  2010-12-14       Impact factor: 8.606

7.  Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.

Authors:  Jue Lin; Candyce H Kroenke; Elissa Epel; Heather A Kenna; Owen M Wolkowitz; Elizabeth Blackburn; Natalie L Rasgon
Journal:  Brain Res       Date:  2010-10-18       Impact factor: 3.252

8.  17β-Estradiol, aging, inflammation, and the stress response in the female heart.

Authors:  James P Stice; Le Chen; Se-Chan Kim; J S Jung; A L Tran; T T Liu; Anne A Knowlton
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

9.  Multiple clinically relevant hormone therapy regimens fail to improve cognitive function in aged ovariectomized rhesus monkeys.

Authors:  Mark G Baxter; Mary T Roberts; Nancy A Gee; Bill L Lasley; John H Morrison; Peter R Rapp
Journal:  Neurobiol Aging       Date:  2013-01-28       Impact factor: 4.673

10.  Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

Authors:  Natalie L Rasgon; Heather A Kenna; Tonita E Wroolie; Ryan Kelley; Daniel Silverman; John Brooks; Katherine E Williams; Bevin N Powers; Joachim Hallmayer; Allan Reiss
Journal:  Neurobiol Aging       Date:  2009-12-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.